Immediate Impact
11 standout
Citing Papers
NF-κB in inflammation and cancer
2025 Standout
Bispecific antibodies: advancing precision oncology
2024 Standout
Works of Melina Arazy being referenced
Weekly selinexor, bortezomib, and dexamethasone (SVd) versus twice weekly bortezomib and dexamethasone (Vd) in patients with multiple myeloma (MM) after one to three prior therapies: Initial results of the phase III BOSTON study.
2020
Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Melina Arazy | 35 | 3 | 31 | 22 | 2 | 36 | |
| Maryana Simonova | 27 | 2 | 22 | 15 | 4 | 28 | |
| Edvan Crusoé | 27 | 2 | 18 | 15 | 3 | 28 | |
| Hans‐Walter Lindemann | 37 | 2 | 19 | 11 | 3 | 43 | |
| D.Y.L. Chang | 40 | 1 | 29 | 28 | 2 | 44 | |
| Brianna Berrios | 24 | 1 | 20 | 13 | 4 | 34 | |
| D. H. Vesole | 42 | 22 | 22 | 2 | 48 | ||
| Edward A. Belter | 17 | 2 | 24 | 9 | 3 | 35 | |
| José-Luis Bello | 50 | 39 | 32 | 3 | 54 | ||
| Cécile Sonntag | 22 | 19 | 11 | 3 | 23 | ||
| Juan Bargay | 31 | 17 | 12 | 4 | 36 |
All Works
Loading papers...